Biomea Fusion (BMEA) Short Interest Ratio & Short Volume $2.30 -0.19 (-7.63%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$2.35 +0.05 (+2.13%) As of 03/28/2025 06:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Biomea Fusion Short Interest DataBiomea Fusion (BMEA) has a short interest of 10.38 million shares, representing 32.82% of the float (the number of shares available for trading by the public). This marks a -6.49% decrease in short interest from the previous month. The short interest ratio (days to cover) is 14.9, indicating that it would take 14.9 days of the average trading volume of 922,181 shares to cover all short positions.Current Short Interest10,380,000 sharesPrevious Short Interest11,100,000 sharesChange Vs. Previous Month-6.49%Dollar Volume Sold Short$26.37 millionShort Interest Ratio14.9 Days to CoverLast Record DateMarch 15, 2025Outstanding Shares36,239,000 sharesFloat Size31,630,000 sharesShort Percent of Float32.82%Today's Trading Volume341,951 sharesAverage Trading Volume922,181 sharesToday's Volume Vs. Average37% Short Selling Biomea Fusion? Sign up to receive the latest short interest report for Biomea Fusion and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBMEA Short Interest Over TimeBMEA Days to Cover Over TimeBMEA Percentage of Float Shorted Over Time Remove Ads Biomea Fusion Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/202510,380,000 shares $26.37 million -6.5%32.8%14.9 $2.54 2/28/202511,100,000 shares $32.08 million +0.7%35.1%14.1 $2.89 2/15/202511,020,000 shares $41.10 million +2.7%34.8%14.4 $3.73 1/31/202510,730,000 shares $44.85 million -12.6%33.9%13.4 $4.18 1/15/202512,280,000 shares $49.86 million +6.4%38.8%14 $4.06 12/31/202411,540,000 shares $44.78 million +6.2%36.5%12.9 $3.88 12/15/202410,870,000 shares $61.31 million +9.6%34.4%11.4 $5.64 11/30/20249,920,000 shares $71.82 million +5.4%31.4%12.8 $7.24 11/15/20249,410,000 shares $61.45 million +11.0%29.7%12.1 $6.53 10/31/20248,480,000 shares $79.46 million +3.5%30.2%11 $9.37 Get the Latest News and Ratings for BMEA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Biomea Fusion and its competitors with MarketBeat's FREE daily newsletter. 10/15/20248,190,000 shares $89.84 million +3.3%29.2%10.1 $10.97 9/30/20247,930,000 shares $80.09 million +4.5%28.3%10.1 $10.10 9/15/20247,590,000 shares $59.58 million -1.4%27.0%10.7 $7.85 8/31/20247,700,000 shares $56.44 million +7.8%27.5%6.9 $7.33 8/15/20247,140,000 shares $41.55 million -8.0%25.5%5.3 $5.82 7/31/20247,760,000 shares $43.22 million -1.8%27.7%5.8 $5.57 7/15/20247,900,000 shares $42.34 million +0.8%28.4%6.3 $5.36 6/30/20247,840,000 shares $35.28 million -33.5%28.2%5.9 $4.50 6/15/202411,790,000 shares $66.50 million -1.2%42.4%8.5 $5.64 5/31/202411,930,000 shares $125.50 million -9.2%42.9%9.8 $10.52 5/15/202413,140,000 shares $173.97 million -5.9%47.2%13.3 $13.24 4/30/202413,970,000 shares $150.04 million +1.1%50.3%14 $10.74 4/15/202413,820,000 shares $172.89 million +4.4%49.9%13.3 $12.51 3/31/202413,240,000 shares $197.94 million +18.2%47.8%13 $14.95 3/15/202411,200,000 shares $199.92 million +6.9%40.6%11.5 $17.85 2/29/202410,480,000 shares $183.40 million -11.0%38.0%8.4 $17.50 2/15/202411,780,000 shares $204.38 million +19.0%42.7%8.6 $17.35 1/31/20249,900,000 shares $178.99 million -3.5%33.5%7.5 $18.08 1/15/202410,260,000 shares $156.05 million +4.0%34.7%8.3 $15.21 12/31/20239,870,000 shares $143.31 million -9.8%33.4%8.3 $14.52 12/15/202310,940,000 shares $155.02 million +23.5%37.0%9.7 $14.17 11/30/20238,860,000 shares $133.52 million +1.7%30.0%9.1 $15.07 11/15/20238,710,000 shares $81.09 million +7.4%29.5%19.5 $9.31 10/31/20238,110,000 shares $82.88 million +3.3%27.5%18.6 $10.22 10/15/20237,850,000 shares $83.52 million -6.6%26.6%17.7 $10.64 9/30/20238,400,000 shares $115.58 million -0.9%28.5%17.7 $13.76 9/15/20238,480,000 shares $128.56 million +4.7%28.8%13.5 $15.16 8/31/20238,100,000 shares $136.65 million +4.7%27.5%10.5 $16.87 8/15/20237,740,000 shares $147.45 million +3.3%26.2%9.4 $19.05 7/31/20237,490,000 shares $166.65 million -9.5%25.4%9 $22.25Why Buffett and 100 members of Congress are Piling into this One Investment (Ad)While everyone's distracted by the recent stock market rally and Trump's tariffs... There's a much bigger story that's flying under the radar for now: Why are Warren Buffett, Ken Griffin, Roman Abramovich, the Koch Brothers, Carlos Slim and at least 100 members of Congress all going against "conventional wisdom?" And why are they all piling into ONE overlooked corner of the stock market? It's not crypto... gold... or options strategies.Don't know where to start investing in AI? Check out my latest investor briefing. 7/15/20238,280,000 shares $190.61 million -0.1%28.1%9.8 $23.02 6/30/20238,290,000 shares $181.97 million +28.5%28.2%9.3 $21.95 6/15/20236,450,000 shares $237.49 million +4.4%21.9%5 $36.82 5/31/20236,180,000 shares $209.87 million +0.3%21.0%6 $33.96 5/15/20236,160,000 shares $209.19 million +1.3%19.7%6.8 $33.96 4/30/20236,080,000 shares $179.18 million +28.5%20.6%7 $29.47 4/15/20234,730,000 shares $113.43 million +114.0%16.2%6 $23.98 3/31/20232,210,000 shares $68.53 million +279.2%7.6%3.2 $31.01 3/15/2023582,800 shares $9.02 million +49.3%2.4%5.8 $15.48 2/28/2023390,300 shares $5.01 million -34.3%1.6%5.2 $12.84 2/15/2023594,000 shares $6.29 million -1.8%2.4%8.9 $10.59 1/31/2023604,700 shares $5.76 million +14.6%2.5%8.9 $9.52 1/15/2023527,900 shares $3.93 million -3.7%2.1%7.5 $7.44 12/30/2022548,400 shares $4.62 million +5.5%2.2%7.9 $8.43 12/15/2022520,000 shares $3.88 million +1.4%2.1%6.9 $7.47 11/30/2022512,700 shares $3.69 million -9.1%2.1%6.2 $7.19 11/15/2022564,100 shares $4.55 million -7.1%2.3%6.3 $8.06 10/31/2022606,900 shares $6.68 million -8.8%2.6%5.4 $11.00 10/15/2022665,500 shares $6.02 million +18.8%2.9%5.8 $9.05 9/30/2022560,300 shares $5.48 million +35.6%2.4%4.2 $9.78 9/15/2022413,200 shares $5.14 million +1.7%1.8%2.2 $12.44 8/31/2022406,400 shares $4.67 million +15.1%1.8%2 $11.50 8/15/2022353,000 shares $4.33 million -21.8%1.5%1.7 $12.27 7/31/2022451,600 shares $4.79 million -17.2%2.0%2 $10.60 7/15/2022545,300 shares $6.58 million -78.2%2.4%2.3 $12.06 6/30/20222,500,000 shares $29.95 million -12.6%10.8%11 $11.98 6/15/20222,860,000 shares $25.08 million +22.2%12.4%13.6 $8.77 5/31/20222,340,000 shares $12.85 million +2.2%12.6%15.5 $5.49 5/15/20222,290,000 shares $8.84 million +4.6%12.3%15.8 $3.86 4/30/20222,190,000 shares $6.57 million +9.5%12.1%21.1 $3.00 4/15/20222,000,000 shares $9.10 million +7.0%11.0%17.6 $4.55 3/31/20221,870,000 shares $8.34 million +5.1%10.3%14.5 $4.46 3/15/20221,780,000 shares $10.40 million +0.6%9.8%12.5 $5.84 2/28/20221,770,000 shares $11.35 million +2.9%9.8%10.3 $6.41 2/15/20221,720,000 shares $10.85 million +22.0%9.5%9.9 $6.31 1/31/20221,410,000 shares $10.10 million +28.2%8.0%7.4 $7.16 1/15/20221,100,000 shares $9.93 million -32.5%6.7%5.7 $9.03 12/31/20211,630,000 shares $12.14 million +4.5%9.9%9.5 $7.45 12/15/20211,560,000 shares $12.93 million +3.3%9.5%10.1 $8.29 11/30/20211,510,000 shares $18.23 million -35.7%9.4%12.2 $12.07 11/15/20212,350,000 shares $27.45 million +13.0%14.6%20.4 $11.68 10/29/20212,080,000 shares $22.34 million +5.6%12.9%20.4 $10.74 10/15/20211,970,000 shares $22.91 million +20.1%12.1%21.8 $11.63 9/30/20211,640,000 shares $19.63 million +13.9%10.1%17.9 $11.97 9/15/20211,440,000 shares $15.31 million +5.1%8.8%13.3 $10.63 8/31/20211,370,000 shares $19.11 million +30.5%8.5%12.3 $13.95 8/13/20211,050,000 shares $11.14 million No Change6.4%9.3 $10.61 BMEA Short Interest - Frequently Asked Questions What is Biomea Fusion's current short interest? Short interest is the volume of Biomea Fusion shares that have been sold short but have not yet been covered or closed out. As of March 15th, investors have sold 10,380,000 shares of BMEA short. 32.82% of Biomea Fusion's shares are currently sold short. Learn More on Biomea Fusion's current short interest. What is a good short interest ratio for Biomea Fusion? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BMEA shares currently have a short interest ratio of 15.0. Learn More on Biomea Fusion's short interest ratio. Which institutional investors are shorting Biomea Fusion? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Biomea Fusion: Wolverine Trading LLC, Sculptor Capital LP, Group One Trading LLC, Citadel Advisors LLC, Rosalind Advisors Inc., Boothbay Fund Management LLC, Diadema Partners LP, Susquehanna International Group LLP, Concourse Financial Group Securities Inc., Affinity Asset Advisors LLC, and Walleye Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Biomea Fusion? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 32.82% of Biomea Fusion's floating shares are currently sold short. Is Biomea Fusion's short interest increasing or decreasing? Biomea Fusion saw a decline in short interest in the month of March. As of March 15th, there was short interest totaling 10,380,000 shares, a decline of 6.5% from the previous total of 11,100,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Biomea Fusion's float size? Biomea Fusion currently has issued a total of 36,239,000 shares. Some of Biomea Fusion's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Biomea Fusion currently has a public float of 31,630,000 shares. How does Biomea Fusion's short interest compare to its competitors? 32.82% of Biomea Fusion's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Biomea Fusion: Eton Pharmaceuticals, Inc. (1.06%), Mereo BioPharma Group plc (4.05%), Revance Therapeutics, Inc. (4.32%), Rapport Therapeutics (13.27%), Solid Biosciences Inc. (11.51%), Heron Therapeutics, Inc. (22.37%), Allogene Therapeutics, Inc. (27.24%), Arcturus Therapeutics Holdings Inc. (18.10%), Astria Therapeutics, Inc. (6.87%), Monte Rosa Therapeutics, Inc. (15.28%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks. What does it mean to sell short Biomea Fusion stock? Short selling BMEA is an investing strategy that aims to generate trading profit from Biomea Fusion as its price is falling. BMEA shares are trading down $0.19 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Biomea Fusion? A short squeeze for Biomea Fusion occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BMEA, which in turn drives the price of the stock up even further. How often is Biomea Fusion's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BMEA, twice per month. The most recent reporting period available is March, 15 2025. More Short Interest Resources from MarketBeat Related Companies ETON Short Interest Data MREO Short Interest Data RVNC Short Interest Data RAPP Short Interest Data SLDB Short Interest Data HRTX Short Interest Data ALLO Short Interest Data ARCT Short Interest Data ATXS Short Interest Data GLUE Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BMEA) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biomea Fusion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biomea Fusion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.